| Page 2 | Kisaco Research
 
Edge AI Summit 2020
18-20 Nov 2020
VIRTUAL SUMMIT | PDT Timezone
A 2020 report by Frost & Sullivan stated that 90% of industrial enterprises will be utilising edge computing by 2022. The value of the data that can be gleaned from intelligence ‘in the field’ is clear, but the current limitations of low power, on-device compute, data management and processing across the edge computing landscape continue to pose multiple engineering challenges. We’re thrilled to announce the agenda for the 3rd annual Edge AI Summit, which was the first ever dedicated summit focused on deploying machine learning on devices, and on the network infrastructure that supports the intelligent IoT. This year is all about Edge AI case studies! From ultra-low-power microwatt applications at the ‘sensor edge’, to larger milliwatt examples at the ‘device edge’ up to the non-power constrained ‘server-network edge’; we’ll be gathering a global audience (virtually!) to explore the most innovative real-world use cases of hardware and software facilitating AI at the Edge with examples from Uber AI, Google, Bosch, Magic Leap, Rakuten and many more…
 
Animal Health, Nutrition and Technology Innovation Europe 2022
21-23 Feb 2022
London, UK
Now in its 7th year, Animal Health, Nutrition and Technology Innovation Europe is the sector’s premier Innovation Summit showcasing the most exciting investment opportunities globally and connecting businesses with investors and strategic corporate partners. Our mission is to engage all key participants in the value chain so we can address the full scope of how animal health impacts pet owners, veterinarians, and farmers today.Following overwhelming feedback from the market, we have significantly expanded our programme this year with new focused content on nutrition and technology, alongside our production and companion animal health content. We will be running 4 separate innovation showcases in production animal health, companion animal health, nutrition, and technology.Our new programme will address the full extent of this ever-evolving market. We are excited to provide an innovation platform that is bigger than ever and to continue to play a critical role in shaping the future of the animal health industry by presenting the most exciting innovations in prediction, prevention, and cure.Book now to come and see for yourself!
 

Lieven Van der Veken

Senior Partner
QuantumBlack, AI by McKinsey

Lieven is a senior partner and leads QuantumBlack, AI by McKinsey, globally and in Europe. A doctor by training, he is a member of our Life Sciences Practice and serves clients across Europe, North America, Asia, and Africa.

Lieven Van der Veken

Senior Partner
QuantumBlack, AI by McKinsey

Lieven Van der Veken

Senior Partner
QuantumBlack, AI by McKinsey

Lieven is a senior partner and leads QuantumBlack, AI by McKinsey, globally and in Europe. A doctor by training, he is a member of our Life Sciences Practice and serves clients across Europe, North America, Asia, and Africa.

Lieven has extensive experience in designing and executing ambitious change journeys, with a particular focus on pharmaceutical companies and biotech as well as public health institutions. For many years, he has led McKinsey’s digital and analytics work across the value chain in life sciences, as well as our global team supporting R&D organizations. He has helped some of the world’s most preeminent institutions leverage the full potential of AI and data while fundamentally changing how teams operate, innovate, and collaborate.

Before joining McKinsey, Lieven qualified as a doctor at the Katholieke Universiteit Leuven and completed an MSc and MPhil in neuroscience at Columbia University. He also worked as a fellow with Columbia’s technology transfer office and as an intern with the Belgian Embassy in the Democratic Republic of the Congo.

 

Cédric Remund

Supervising Prosecutor for General Economic Crime Cases
Office of the Attorney General of Switzerland

Cédric Remund

Supervising Prosecutor for General Economic Crime Cases
Office of the Attorney General of Switzerland

Cédric Remund

Supervising Prosecutor for General Economic Crime Cases
Office of the Attorney General of Switzerland
 

Alyssa Rapp

CEO
Empower Aesthetics

Alyssa Rapp

CEO
Empower Aesthetics

Alyssa Rapp

CEO
Empower Aesthetics
 

Dr. Rebecca Robbins

Assistant Professor
Harvard Medical School

Dr. Rebecca Robbins is Assistant Professor in Medicine at Harvard Medical School and an Associate Scientist at the Brigham and Women’s Hospital. Her research is focused on uncovering the connection between the quantity and quality of sleep and various dimensions of waking success, from cognitive to physical and emotional health and well being. Dr. Robbins has published more than 100 peer-reviewed articles and 20 encyclopedia chapters.

Dr. Robbins is Co Author of Sleep for Success!

Dr. Rebecca Robbins

Assistant Professor
Harvard Medical School

Dr. Rebecca Robbins

Assistant Professor
Harvard Medical School

Dr. Rebecca Robbins is Assistant Professor in Medicine at Harvard Medical School and an Associate Scientist at the Brigham and Women’s Hospital. Her research is focused on uncovering the connection between the quantity and quality of sleep and various dimensions of waking success, from cognitive to physical and emotional health and well being. Dr. Robbins has published more than 100 peer-reviewed articles and 20 encyclopedia chapters.

Dr. Robbins is Co Author of Sleep for Success!

Dr. Robbins makes frequent television appearances, including the Today Show, Live! with Kelly Ripa and Ryan Seacrest, and Good Morning America.  

Dr. Robbins has held teaching positions at Harvard College, the Harvard TH Chan School of Public Health and the Weill Cornell Medical College in Doha, Qatar.

 

Allison Beller

Partner
Prelude Growth Partners

Allison Beller is a partner at Prelude Growth Partners, a New York-based, female-founded consumer growth fund. Prior to joining Prelude, Allison was a Managing Director at Goldman Sachs & Co in the Private Equity group within the Asset Management Division, where she worked for over 18 years. Her investing experience covered the Consumer and Services landscape. Allison began her career at Credit Suisse First Boston in the Financial Sponsors group.

Allison Beller

Partner
Prelude Growth Partners

Allison Beller

Partner
Prelude Growth Partners

Allison Beller is a partner at Prelude Growth Partners, a New York-based, female-founded consumer growth fund. Prior to joining Prelude, Allison was a Managing Director at Goldman Sachs & Co in the Private Equity group within the Asset Management Division, where she worked for over 18 years. Her investing experience covered the Consumer and Services landscape. Allison began her career at Credit Suisse First Boston in the Financial Sponsors group. Allison received a Bachelors of Science in Finance from The Wharton School of the University of Pennsylvania.